The table below shows Context Therapeutics Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$11.43M
-$5.03M
-$4.36M
-$5.73M
-$3.82M
-$1.72M
Capital expenditure
$37.26K
$33.95K
$0.00
$0.00
$35.00K
$0.00
Investing cash flow
-$37.26K
-$33.95K
$0.00
$0.00
-$35.00K
$0.00
Dividends paid
-
-
-
-
CNTX operating cash flow (10-K history)
Context Therapeutics Inc. reported operating cash flow of -$26.39M for fiscal year 2025. That is down 81.3% from -$14.56M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$1.03M (FY 2020) to -$26.39M. Figures come from the company's audited annual reports as filed with the SEC.